Abingdon Health Plc (ABDX.L)

LSE • Currency in GBP

£6.25

-£0.25

-3.85%

Last Update: 16 Jul 2025, 16:06

£12.10M

Market Cap

0.00

P/E Ratio (TTM)

P/E Ratio

—

Forward Dividend Yield

Forward Yield

£5.50 - £11.50

52 Week Range

ABDX.L Stock Price Chart

Explore Abingdon Health Plc interactive price chart. Choose custom timeframes to analyze ABDX.L price movements and trends.

There is nothing to show.

ABDX.L Company Profile

Discover essential business fundamentals and corporate details for Abingdon Health Plc (ABDX.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

IPO Date

15 Dec 2020

Employees

113.00

Website

https://www.abingdonhealth.com

CEO

Christopher William Hand

Description

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. The company also provides lateral flow development and manufacturing services. Additionally, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

ABDX.L Financial Timeline

Browse a chronological timeline of Abingdon Health Plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Mar 2026

Upcoming earnings on 6 Oct 2025

Earnings released on 24 Mar 2025

EPS came in at -£0.01, while revenue for the quarter reached £3.09M.

Earnings released on 8 Oct 2024

EPS came in at -£0.00, while revenue for the quarter reached £3.73M, missing expectations by -56.69%.

Earnings released on 14 Mar 2024

EPS came in at -£0.00, while revenue for the quarter reached £2.41M.

Earnings released on 17 Oct 2023

EPS came in at -£0.00, while revenue for the quarter reached £2.93M.

Earnings released on 31 Mar 2023

EPS came in at -£0.01, while revenue for the quarter reached £1.11M.

Earnings released on 24 Nov 2022

EPS came in at -£0.13, while revenue for the quarter reached £1.13M.

Earnings released on 31 Dec 2021

EPS came in at -£0.05, while revenue for the quarter reached £1.70M.

Earnings released on 30 Jun 2021

EPS came in at -£0.07, while revenue for the quarter reached £3.93M.

Earnings released on 9 Mar 2021

EPS came in at £0.00, while revenue for the quarter reached £7.69M.

Earnings released on 15 Dec 2020

ABDX.L Stock Performance

Access detailed ABDX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.